- Home
- HUMA vs QD Comparison
HUMA vs QD Comparison
Compare HUMA & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- QD
- Stock Information
- Founded
- HUMA 2004
- QD 2014
- Country
- HUMA United States
- QD China
- Employees
- HUMA N/A
- QD N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- QD Finance: Consumer Services
- Sector
- HUMA Health Care
- QD Finance
- Exchange
- HUMA Nasdaq
- QD Nasdaq
- Market Cap
- HUMA 427.2M
- QD 433.7M
- IPO Year
- HUMA N/A
- QD 2017
- Fundamental
- Price
- HUMA $1.96
- QD $2.63
- Analyst Decision
- HUMA Strong Buy
- QD
- Analyst Count
- HUMA 6
- QD 0
- Target Price
- HUMA $14.60
- QD N/A
- AVG Volume (30 Days)
- HUMA 4.1M
- QD 465.8K
- Earning Date
- HUMA 03-28-2025
- QD 03-20-2025
- Dividend Yield
- HUMA N/A
- QD N/A
- EPS Growth
- HUMA N/A
- QD N/A
- EPS
- HUMA N/A
- QD 0.03
- Revenue
- HUMA N/A
- QD $32,502,011.00
- Revenue This Year
- HUMA N/A
- QD N/A
- Revenue Next Year
- HUMA $3,797.96
- QD N/A
- P/E Ratio
- HUMA N/A
- QD $98.08
- Revenue Growth
- HUMA N/A
- QD 4.27
- 52 Week Low
- HUMA $1.76
- QD $1.52
- 52 Week High
- HUMA $9.97
- QD $3.34
- Technical
- Relative Strength Index (RSI)
- HUMA 26.93
- QD 41.24
- Support Level
- HUMA $1.96
- QD $2.59
- Resistance Level
- HUMA $3.36
- QD $2.74
- Average True Range (ATR)
- HUMA 0.24
- QD 0.13
- MACD
- HUMA -0.09
- QD -0.01
- Stochastic Oscillator
- HUMA 12.50
- QD 4.17
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.